Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized open-label study of three ethinylestradiol/gestodene transdermal contraceptive patches
2010-021255-81Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ethinyl estradiol and gestodene in contraception (3 arms), sponsored by Bayer. Primary endpoint: Proportion of volunteers with ovulation in at least one of treatment cycles 2 and 3. Started Aug 2010; status: completed.
02
Drugs
ethinyl estradiolgestodene
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-021255-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021255-81.